| |
Pink, your unsubstantiated scare remarks are beneath the tenor of a scholarly discussion, and indicate your bias and level of study. I challenge you to point to some balance sheet or cash flow statements supporting your gratuitous remarks. You may also wish to consider the possibility of discussing with an attorney the possibility of tort liability for slander of credit. Concern over such liability may be one reason your 'profile' reveals so little about you.
The most recent SEC filings don't seem to support your bald assertion. Perhaps, Mr. Pink, you could reconcile for readers your little slap against the following statements in the most recent 10Q from sec.yahoo.com
Quoting:
"In September 1997, the Company completed a follow-on public offering of 2,785,000 shares of Common Stock raising net proceeds of $93,320,000 (the "1997 Public Offering").
Net cash used in operating activities for the quarter ended March 31, 1998 was $7,233,000. The funds were used primarily to purchase technology in progress and for restructuring costs in connection with the Xyplex Acquisition. Net cash provided by investing activities for the three months ended March 31, 1998 was $2,753,000. The cash provided by investing activities primarily resulted from the sale of investments in U.S. Government securities to finance the Xyplex Acquisition.
Accounts receivable were $59,472,000 at March 31, 1998 as compared to $47,258,000 at December 31, 1997. The increase in accounts receivable was primarily attributable to the increase in overall sales in Europe where terms of sale are traditionally longer than in the U.S.
(endquote ... emphasis added)
Perhaps its the annual statement you were thinking of? No, that can't be it, because the 10K at
sec.yahoo.com
states:
(quoting ... emphasis added)
"Net cash used in operating activities for the years ended December 31, 1997 was $2,761,000. The funds were used primarily for increased inventories and receivables as a result of increased revenues. Net cash provided by financing activities for year December 31, 1997 and 1996 were $95,153,000 and $38,882,000, respectively. The cash provided by financing activities in 1997 came principally from the proceeds from 1997 Public Offering, which were partially offset by the repurchase of the Common Stock from Elbit. Net cash used in investing activities for the year ended December 31, 1997 was $87,454,000. The cash used in investing activities was primarily used to purchase investments in U.S. Government securities. "
Mr. Pink, please explain how you reached the conclusion that you did regarding the "inevitable" destiny of MRVC. Or is factual support not in your repertoire?
Doug (long MRVC). |
|
